Grail (NASDAQ:GRAL) Stock Price Down 4.4% – Should You Sell?

Grail, Inc. (NASDAQ:GRAL)’s stock price fell 4.4% on Thursday . The company traded as low as $16.78 and last traded at $16.80. 206,992 shares changed hands during mid-day trading, a decline of 68% from the average session volume of 640,543 shares. The stock had previously closed at $17.58.

Analyst Ratings Changes

GRAL has been the subject of a number of analyst reports. Wolfe Research assumed coverage on shares of Grail in a research report on Friday, November 15th. They set a “peer perform” rating for the company. Guggenheim assumed coverage on shares of Grail in a report on Thursday, October 17th. They set a “neutral” rating for the company. Finally, Morgan Stanley began coverage on Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price objective on the stock.

Grail Price Performance

The stock’s 50 day moving average is $18.32.

Insider Transactions at Grail

In related news, CFO Aaron Freidin sold 30,452 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the sale, the chief financial officer now owns 268,277 shares of the company’s stock, valued at approximately $3,761,243.54. This represents a 10.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Hedge Funds Weigh In On Grail

A number of institutional investors have recently made changes to their positions in the stock. Douglas Lane & Associates LLC purchased a new stake in Grail during the 4th quarter worth about $3,034,000. 180 Wealth Advisors LLC purchased a new stake in shares of Grail during the fourth quarter worth about $1,681,000. Wesbanco Bank Inc. acquired a new position in shares of Grail in the fourth quarter valued at approximately $523,000. A. D. Beadell Investment Counsel Inc. acquired a new position in shares of Grail in the fourth quarter valued at approximately $430,000. Finally, B & T Capital Management DBA Alpha Capital Management purchased a new position in shares of Grail during the fourth quarter valued at approximately $387,000.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.